Is it different than HUM.AX?

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking whether HUM (Humana Inc.) is different from HUM.AX. From the references provided, I see that HUM.AX refers to Axos Financial Inc., which is a different company. The user is a sophisticated investor with interests in fintech, meme stocks, and tech sectors, so they might be confused between the two tickers. First, I need to check the data. The references mention both HUM and HUM.AX. Looking at the stock codes, HUM is Humana Inc., a healthcare provider, while HUM.AX is Axos Financial Inc., a fintech company. The user might have seen both tickers and wondered if they're related or the same. I should compare their financials, market positions, and recent news. The user's profile mentions a focus on fintech, so highlighting Axos Financial's fintech aspects would be relevant. Also, the user has a high risk tolerance, so pointing out the risks and growth potential in both companies could be useful. Let me structure the answer by first stating the conclusion that they are different companies. Then, break down the analysis into sections like market positioning, financials, institutional activity, and risks. Use tables to present the data clearly. Make sure to cite the references properly and include the required visualizations for the queries mentioned. I need to ensure the answer is comprehensive but not just listing data. The user wants insights, so comparing the two companies' strengths and risks in the context of their investment strategy is key. Also, since the user prefers blue-chip stocks, note that Humana is a larger, more established company, while Axos is smaller but growing in fintech. Finally, wrap up with a recommendation based on the user's profile, emphasizing which might align better with their interests in fintech and high-risk tolerance. Make sure to use the correct citations and include the visualizations as specified. ``` ### 🌟 **Conclusion** **HUM (Humana Inc.)** and **HUM.AX (Axos Financial Inc.)** are **completely different companies** operating in distinct industries with varying financial profiles and market dynamics. While both stocks have shown recent price volatility, their **fundamental differences** in business models, financial health, and growth trajectories make them **unrelated**. Let’s break it down: --- ### 📊 **Key Analysis** #### 1. **Market Positioning** | Metric | HUM (Humana Inc.) | HUM.AX (Axos Financial Inc.) | |------------------------|-----------------------------------|---------------------------------------------| | **Industry** | Healthcare Insurance | Fintech/Banking Services | | **Market Cap** | $30.46B (2025-07-02) | $2.2B (2025-07-02) | | **Revenue (2025Q1)** | $32.11B | $308.84M | | **Net Income (2025Q1)**| $1.24B | $105.21M | | **Growth (3-Year CAGR)**| Revenue: 12.61% | Revenue: 31.04% | |code|Ticker|Name|Date|Total Revenue|market_code| |---|---|---|---|---|---| |HUM|HUM.N|Humana|2024 Q4|2.9213E10|169| |HUM|HUM.N|Humana|2025 Q1|3.2112E10|169| |code|Ticker|Name|Date|Net Income|market_code| |---|---|---|---|---|---| |HUM|HUM.N|Humana|2024 Q4|-6.83E8|169| |HUM|HUM.N|Humana|2025 Q1|1.242E9|169| |code|Ticker|Name|Date|Diluted EPS|market_code| |---|---|---|---|---|---| |HUM|HUM.N|Humana|2024 Q4|-5.76|169| |HUM|HUM.N|Humana|2025 Q1|10.3|169| |code|Ticker|Name|Date|Net Income YoY|Total Revenue YoY|Diluted EPS YoY|market_code| |---|---|---|---|---|---|---|---| |HUM|HUM.N|Humana|2024 Q2|-29.079497907949794|10.442292593561895|-26.631853785900784|169| |HUM|HUM.N|Humana|2024 Q3|-42.168674698795186|11.255345721530485|-40.68554396423249|169| |HUM|HUM.N|Humana|2024 Q4|-26.481481481481485|10.396039603960396|-30.316742081447963|169| |HUM|HUM.N|Humana|2025 Q1|68.06495263870094|8.446185539157746|68.57610474631751|169| #### 2. **Financial Health** | Metric | HUM (Humana Inc.) | HUM.AX (Axos Financial Inc.) | |------------------------|-------------------------------|-------------------------------------------| | **P/E Ratio (TTM)** | 16.06 | 9.60 | | **P/S Ratio (TTM)** | 0.25 | 3.59 | | **Free Cash Flow** | N/A | $156.41M (2025Q2) | | **Debt-to-Equity** | 0.71 | N/A | #### 3. **Institutional Activity** - **HUM**: 92.38% institutional ownership . Recent activity includes **KBC Group NV** reducing stake (-5.6%) and **Robeco** increasing stake (+502%) . - **HUM.AX**: No direct institutional activity mentioned in recent filings . #### 4. **Risks & Catalysts** - **HUM**: Regulatory risks (Medicare reforms), high debt levels, and low cash-to-debt ratio (0.32) . - **HUM.AX**: Tax law changes in California (one-time $4M impairment) . --- ### 🎯 **Final Take** For a **sophisticated investor** with a **high-risk tolerance** and interest in **fintech**, **HUM.AX (Axos Financial)** may align better with your portfolio strategy due to its **small-cap growth potential** and **digital banking focus**. However, **HUM (Humana Inc.)** offers **stability** in the healthcare sector with **consistent dividends** and **long-term contracts**. Both stocks require **close monitoring** of their respective risks and catalysts. Let me know if you’d like to dive deeper into either company! 🚀